©The Author(s) 2023.
World J Gastrointest Endosc. Jun 16, 2023; 15(6): 480-490
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.480
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.480
Table 2 Comparison of presenting symptoms in patients with and without esophageal candidiasis, n (%)
| Presenting symptom | EC1 patients, n = 177 | Matched controls, n = 247 |
| Dysphagia | 52 (16.94) | 52 (11.95) |
| Nausea | 46 (14.98) | 76 (17.47) |
| Melena | 45 (14.66) | 58 (13.33) |
| Vomiting | 42 (13.68) | 79 (18.16) |
| Hematemesis | 26 (8.47) | 44 (10.11) |
| Epigastric pain | 21 (6.84) | 22 (5.06) |
| Weight loss | 18 (5.86) | 8 (1.84) |
| Non-specific | 17 (5.54) | 36 (8.28) |
| Abdominal pain | ||
| Diarrhea | 13 (4.23) | 7 (1.61) |
| Chest pain | 12 (3.91) | 18 (4.14) |
| Asymptomatic | 11 (3.58) | 11 (2.53) |
| Odynophagia | 10 (3.26) | 11 (2.53) |
| Dyspepsia | 6 (1.95) | 9 (2.07) |
| Acid reflux | 5 (1.63) | 2 (0.46) |
| Unknown | 0 (0.00) | 2 (0.46) |
- Citation: Kimchy AV, Ahmad AI, Tully L, Lester C, Sanghavi K, Jennings JJ. Prevalence and clinical risk factors for esophageal candidiasis in non-human immunodeficiency virus patients: A multicenter retrospective case-control study. World J Gastrointest Endosc 2023; 15(6): 480-490
- URL: https://www.wjgnet.com/1948-5190/full/v15/i6/480.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i6.480